ASX:PMEHealthcare Services
What Pro Medicus (ASX:PME)'s Final Dividend Increase and Strong Results Mean For Shareholders
Pro Medicus Limited recently reported full-year results for the period ended June 30, 2025, highlighting A$220.54 million in revenue, A$115.22 million in net income, and an increased franked final dividend of 30.0 cents per share.
The company’s strong financial performance was accompanied by a substantial rise in both earnings and the dividend, reflecting a notable commitment to rewarding shareholders.
Let’s explore how the larger franked dividend underscores Pro Medicus’ evolving investment...